GIM
SRNE

Goelzer Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Goelzer Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,000
Closed -$10.6K – 244
2022
Q4 		$10.6K Hold
12,000
– – ﹤0.01% 237
2022
Q3 		$19K Hold
12,000
– – ﹤0.01% 223
2022
Q2 		$24K Hold
12,000
– – ﹤0.01% 220
2022
Q1 		$28K Buy
+12,000
New +$37.4K ﹤0.01% 216

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Goelzer Investment Management's SRNE Position: Q1 2023 in Review

Goelzer Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 12,000 shares — an estimated $10.6K sold.

Goelzer Investment Management first reported a position in SRNE in Q1 2022 and held it in 4 quarters. The position peaked at $28K in Q1 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Goelzer Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Goelzer Investment Management sold 12,000 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $10.6K.
  • Goelzer Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2022 and held it in 4 quarters.
  • Goelzer Investment Management's Sorrento Therapeutics, Inc. position peaked at $28K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Goelzer Investment Management's 13F filing for Q1 2023, filed 28 Apr 2023.